8-K//Current report
Fusion Pharmaceuticals Inc. 8-K
Accession 0000950170-24-053948
CIK 0001805890operating
Filed
May 6, 8:00 PM ET
Accepted
May 7, 7:30 AM ET
Size
289.7 KB
Accession
0000950170-24-053948
Documents
- 8-Kfusn-20240507.htmPrimary
8-K
- EX-99.1fusn-ex99_1.htm
EX-99.1
- GRAPHICimg92740539_0.jpg
GRAPHIC
- EX-101.SCHfusn-20240507.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-24-053948-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLfusn-20240507_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Fusion Pharmaceuticals Inc.
CIK 0001805890
Entity typeoperating
IncorporatedCanada (Federal Level)
Related Parties
1- filerCIK 0001805890
Filing Metadata
- Form type
- 8-K
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 7:30 AM ET
- Size
- 289.7 KB